Fairmount Funds Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Hold |
3,554,129
| – | – | 2.47% | 14 |
|
|
2025
Q1 | $19M | Hold |
3,554,129
| – | – | 2.94% | 12 |
|
|
2024
Q4 | $31.8M | Hold |
3,554,129
| – | – | 3.16% | 13 |
|
|
2024
Q3 | $39.1M | Hold |
3,554,129
| – | – | 3.17% | 12 |
|
|
2024
Q2 | $32.3M | Hold |
3,554,129
| – | – | 3.65% | 9 |
|
|
2024
Q1 | $50M | Hold |
3,554,129
| – | – | 5.45% | 7 |
|
|
2023
Q4 | $27.3M | Buy |
3,554,129
+1,652,732
| +87% | +$12.7M | 2.88% | 10 |
|
|
2023
Q3 | $14.2M | Hold |
1,901,397
| – | – | 1.71% | 16 |
|
|
2023
Q2 | $15.8M | Hold |
1,901,397
| – | – | 2.23% | 11 |
|
|
2023
Q1 | $25.3M | Hold |
1,901,397
| – | – | 4.35% | 9 |
|
|
2022
Q4 | $28.3M | Buy |
1,901,397
+989,661
| +109% | +$14.7M | 4.49% | 9 |
|
|
2022
Q3 | $8.24M | Hold |
911,736
| – | – | 1.45% | 21 |
|
|
2022
Q2 | $2.74M | Hold |
911,736
| – | – | 0.63% | 26 |
|
|
2022
Q1 | $6.12M | Hold |
911,736
| – | – | 1.45% | 19 |
|
|
2021
Q4 | $4.91M | Hold |
911,736
| – | – | 1.62% | 19 |
|
|
2021
Q3 | $8.06M | Buy |
911,736
+229,708
| +34% | +$2.03M | 2.93% | 15 |
|
|
2021
Q2 | $8.63M | Buy |
682,028
+673,167
| +7,597% | +$8.52M | 3.55% | 13 |
|
|
2021
Q1 | $154K | Buy |
+8,861
| New | +$154K | 0.06% | 21 |
|